Jakubowski H
Department of Microbiology and Molecular Genetics, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark 07103.
Proc Natl Acad Sci U S A. 1990 Jun;87(12):4504-8. doi: 10.1073/pnas.87.12.4504.
Previous in vitro studies have established a pre-transfer proofreading mechanism for editing of homocysteine by bacterial methionyl-, isoleucyl-, and valyl-tRNA synthetases. The unusual feature of the editing is the formation of a distinct compound, homocysteine thiolactone. Now, two-dimensional TLC analysis of 35S-labeled amino acids extracted from cultures of the bacterium Escherichia coli reveals that the thiolactone is also synthesized in vivo. In E. coli, the thiolactone is made from homocysteine in a reaction catalyzed by methionyl-tRNA synthetase. One molecule of homocysteine is edited as thiolactone per 109 molecules of methionine incorporated into protein in vivo. These results not only directly demonstrate that the adenylate proofreading pathway for rejection of misactivated homocysteine operates in vivo in E. coli but, in general, establish the importance of error-editing mechanisms in living cells.
先前的体外研究已经建立了一种预转移校对机制,用于细菌甲硫氨酰 - 、异亮氨酰 - 和缬氨酰 - tRNA合成酶对同型半胱氨酸的编辑。这种编辑的不寻常特征是形成一种独特的化合物——同型半胱氨酸硫内酯。现在,对从大肠杆菌培养物中提取的35S标记氨基酸进行的二维薄层层析分析表明,硫内酯也在体内合成。在大肠杆菌中,硫内酯由同型半胱氨酸在甲硫氨酰 - tRNA合成酶催化的反应中生成。在体内每掺入109个甲硫氨酸分子到蛋白质中,就有一个同型半胱氨酸分子被编辑为硫内酯。这些结果不仅直接证明了用于排斥错误激活的同型半胱氨酸的腺苷酸校对途径在大肠杆菌体内起作用,而且总体上确立了错误编辑机制在活细胞中的重要性。